FIELD: chemistry.
SUBSTANCE: invention relates to a compound of formula (5): wherein n represents 0, and R11 is hydroxyl, or its tautomer, racemate or stereoisomer thereof, which is intermediate compound for producing cyclopropane particularly 2-amino-9-[[1S,2R)-1,2-bis (hydroxymethyl)cyclopropyl]methyl]-1,9-purine-6-one, which has antiviral activity, as well as method for preparing them.
EFFECT: obtaining cyclopropane derivatives.
11 cl
| Title | Year | Author | Number |
|---|---|---|---|
| APPLICATION OF ATASANAVIR FOR IMPROVEMENT OF PHARMAKINETICS OF UGT1A1-METABOLISED MEDICATIONS | 2005 |
|
RU2403066C2 |
| IMIDAZOPYRIDINE COMPOUNDS AS PAD INHIBITORS | 2018 |
|
RU2782743C2 |
| PIPERIDINE-AMINO-BENZIMIDAZOLE DERIVATIVES AS INHIBITORS OF RESPIRATORY SYNCYTIAL VIRUS REPLICATION | 2004 |
|
RU2381224C2 |
| HIV INHIBITING 5-HETEROCYCLYL PYRIMIDINES | 2005 |
|
RU2405778C2 |
| 1,2,4-TRIAZINE-6-ONE DERIVATIVES, INHIBITING HIV | 2005 |
|
RU2401833C2 |
| SUBSTITUTED QUINAZINE DERIVATIVES AS FGFR-KINASE INHIBITORS FOR TREATMENT OF CANCER | 2011 |
|
RU2602233C2 |
| HIV-INHIBITING 5-AMIDO-SUBSTITUTED PYRIMIDINES | 2007 |
|
RU2480464C2 |
| USING SIP RECEPTOR MODULATOR | 2008 |
|
RU2498796C2 |
| OPTIONALLY CONDENSED HETEROCYCLYL-SUBSTITUTED PYRIMIDINE DERIVATIVES SUITABLE FOR TREATING INFLAMMATORY, METABOLIC, ONCOLOGICAL AND AUTOIMMUNE DISEASES | 2015 |
|
RU2719422C2 |
| HIV-INHIBITING BICYCLIC PYRIMIDIN DERIVATIVES | 2005 |
|
RU2403254C2 |
